Phase I trial of alpha-particle immunotherapy with (225)Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia Meeting Abstract
| Authors: | Jurcic, J.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B.; Orozco, J.; Estey, E.; Kantarjian, H.; Cicic, D.; Scheinberg, D. |
| Abstract Title: | Phase I trial of alpha-particle immunotherapy with (225)Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia |
| Meeting Title: | 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 58 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Jun 10-14 |
| Meeting Location: | Denver, CO |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2017-05-01 |
| Start Page: | 456 |
| Language: | English |
| ACCESSION: | WOS:000404949902065 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
MSK Authors
-
356Park -
499Scheinberg